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Abstract
Mosquito-borne alphaviruses such as chikungunya virus and Ross River virus (RRV) are emerging pathogens capable of
causing large-scale epidemics of virus-induced arthritis and myositis. The pathology of RRV-induced disease in both humans
and mice is associated with induction of the host inflammatory response within the muscle and joints, and prior studies
have demonstrated that the host complement system contributes to development of disease. In this study, we have used a
mouse model of RRV-induced disease to identify and characterize which complement activation pathways mediate disease
progression after infection, and we have identified the mannose binding lectin (MBL) pathway, but not the classical or
alternative complement activation pathways, as essential for development of RRV-induced disease. MBL deposition was
enhanced in RRV infected muscle tissue from wild type mice and RRV infected MBL deficient mice exhibited reduced
disease, tissue damage, and complement deposition compared to wild-type mice. In contrast, mice deficient for key
components of the classical or alternative complement activation pathways still developed severe RRV-induced disease.
Further characterization of MBL deficient mice demonstrated that similar to C3
2/2 mice, viral replication and inflammatory
cell recruitment were equivalent to wild type animals, suggesting that RRV-mediated induction of complement dependent
immune pathology is largely MBL dependent. Consistent with these findings, human patients diagnosed with RRV disease
had elevated serum MBL levels compared to healthy controls, and MBL levels in the serum and synovial fluid correlated with
severity of disease. These findings demonstrate a role for MBL in promoting RRV-induced disease in both mice and humans
and suggest that the MBL pathway of complement activation may be an effective target for therapeutic intervention for
humans suffering from RRV-induced arthritis and myositis.
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Introduction
Arthritogenic alphaviruses, such as Ross River virus (RRV) and
chikungunya virus (CHIKV), are mosquito-borne viruses that
cause severe polyarthritis and myositis in humans. RRV causes
annual disease outbreaks in Australia and has caused sporadic
epidemics of debilitating polyarthritis, including one outbreak
involving over 60,000 people in Oceania [1]. RRV is transmitted
to humans primarily by the Aedes and Culex species of mosquitoes
that generally populate marsh areas, and CHIKV transmission has
been traditionally mediated by the urban Aedes aegypti, though the
virus has recently adapted for efficient transmission by the widely
distributed Aedes albopictus species [2], leading to an increased risk
for CHIKV spread into new areas, as illustrated by recent
outbreaks in Italy and southern France [3]. The expansion of
CHIKV into an additional mosquito vector and the subsequent
epidemic has highlighted the ability of the arthritic alphaviruses to
move into new geographic areas and cause large-scale outbreaks of
acute and persistent arthralgia and myalgia in humans.
RRV-induced arthritic disease presents predominantly as
painful stiffness, inflammation, and swelling in peripheral joints
that can last months after initial infection and the host
inflammatory response is thought to play a major role in disease
pathogenesis. Inflammatory monocytes constitute the bulk of
leukocytes isolated in synovial aspirates from RRV-infected
patients [4,5], and macrophage-cytotoxic drugs have been shown
to drastically reduce disease progression and severity in mice [6,7].
In addition, mice lacking C3, the central complement factor that is
essential for complement activation, exhibit reduced RRV-
induced disease and tissue destruction [8], implicating a role for
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in mice, synovial aspirates from patients with RRV-induced
arthritis have been shown to contain increased levels of the C3
cleavage product C3a [8]. Although macrophage recruitment to
infected tissues is markedly increased after RRV infection, the role
played by complement is independent of inflammatory cell
recruitment. Rather, tissue destruction and disease progression
requires complement receptor 3 (CR3), suggesting that comple-
ment interactions with CR3 on inflammatory cells promote tissue
destruction in RRV-infected tissues [9]. However, it is currently
unclear how the complement system is activated following RRV
infection.
There are three main activation pathways of the complement
cascade; the classical, alternative, and lectin dependent pathways,
that all converge on factor C3 and lead to activation of
complement effector functions (reviewed in [10]). The classical
pathway is initiated by C1q interactions with antigen-bound
complexes of IgG and IgM, and the proteases C1r and C1s cleave
C4 and C2 to generate the C3 convertase C4b2b. Binding of
factor B (fB) and spontaneously hydrolyzed C3 initiates the
alternative pathway, and fB binding to C3b leads to formation of
the alternative C3 convertase C3bBb that can amplify comple-
ment activation. In the lectin pathway, mannose binding lectin
(MBL) or the ficolins bind to carbohydrate moieties on foreign
bodies, such as viruses, or to host cells and apoptotic cells, and the
MBL-associated serine proteases (MASPs) cleave C4 and C2 to
form the C3 convertase C4b2b. Cleavage and processing of C3 by
the C3 convertases produce several C3-derived components that
are potent activators of the immune system. One such component
is iC3b, which is a ligand for several complement receptors, such
as CR3. Binding of iC3b to CR3 on cells such as monocytes/
macrophages, neutrophils, and NK cells, results in activation of
these cells, leading to enhanced phagocytosis and cytotoxic activity
against iC3b-opsonized cells [10].
MBL is a soluble C-type lectin that can initiate the complement
cascade through binding of the carbohydrate recognition domains
(CRD) to cell-surface sugars expressed on bacteria and viruses and
some endogenous host ligands (reviewed in [11]). The complement
system is notorious for having both a protective and pathologic
role and frequently leads to additional tissue injury and damage
once activated. Similarly, MBL appears to be able to have the
ability to protect as well as harm the host cells. In the context of
sterile inflammatory diseases such as myocardial and gastrointes-
tinal ischemic reperfusion injury, MBL and the lectin pathway
mediate development of disease through complement-mediated
regulation of pro-inflammatory cytokines and inflammation,
leading to exacerbated pathology and tissue injury [12–15]. In
contrast to the pathologic role of MBL in sterile inflammatory
diseases, MBL is thought to primarily play a protective role in
response to infectious pathogens. MBL has been shown to be
essential for host protection from many different viral and
bacterial infections either through direct binding to pathogens or
by limiting spread through complement effector functions. MBL
has been shown to bind directly to many different viruses,
including human immunodeficiency virus (HIV), Ebola virus, and
arboviruses such as dengue virus and West Nile virus (WNV), and
MBL can either directly neutralize these viruses through activation
of complement or interfere with their binding to host cells
(reviewed in [16]). Furthermore, studies using mice deficient in
both MBL genes (MBL-A
2/2 and MBL-C
2/2; MBL-DKO) have
revealed that MBL can have a protective role during WNV and
herpes simplex virus infections [17–19]. Though MBL neutralizes
flaviviruses, such as WNV and dengue virus [18], and plays a
protective role during WNV infection [19], these same studies
found no detectable interactions between MBL and alphaviruses,
suggesting that MBL does not play a protective role during
alphavirus infection. However, the role of MBL role in the
pathogenesis of alphavirus-induced arthritis/myositis has not been
evaluated.
The goal of this study was to further assess the role of the host
complement system in the pathogenesis of alphavirus-induced
inflammatory disease and to determine which complement
activation pathways are required for virus-induced disease. In a
mouse model of RRV-induced arthritis and myositis, mice
deficient in either the classical or alternative pathways developed
severe disease, while mice deficient in both genes of MBL (MBL-
DKO) were resistant to disease, suggesting that MBL plays a
major role in RRV-induced disease. Similar to previous findings
with C3
2/2 mice [8], RRV-infected MBL-DKO mice had similar
levels of viral burden and inflammation compared to wild-type
(WT) but exhibited significantly less complement deposition, tissue
damage, and disease. Further analysis found that MBL levels are
enhanced in RRV infected tissues and that MBL binds to RRV
infected cells, suggesting that RRV infection leads to MBL
deposition and subsequent complement activation. Importantly,
studies in human patients suffering from RRV-induced disease
found that levels of MBL were elevated in the serum of RRV-
infected patients compared to healthy controls. In addition, serum
and synovial fluid MBL levels correlated with the severity of RRV
disease, while no differences were observed in classical or
alternative pathway activation, suggesting that MBL contributes
to RRV-induced disease in human populations.
Results
The MBL pathway is essential for RRV-induced disease
and inflammatory tissue destruction
Complement activation products are elevated in the synovial
fluid of persons suffering from RRV-induced arthritis and
complement activation is required for virus-induced arthritis/
myositis in a mouse model [8,9,20]. Although other alphaviruses,
such as the neurovirulent Sindbis virus, have been shown to
activate complement via both the classical and alternative
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and chikungunya virus are transmitted to humans by
mosquitoes and cause epidemics of debilitating infectious
arthritis and myositis in various areas around the world.
Studies in humans and mice indicate that the host
inflammatory response is critical for development of RRV-
induced arthritis and myositis, and the host complement
system, a component of the host inflammatory response,
plays an essential role in the development of RRV-induced
disease through activation of complement receptor 3
(CR3)-bearing inflammatory cells. Of the three main
complement activation pathways, only the lectin pathway
activated by mannose binding lectin (MBL) was essential
for RRV-induced complement activation, tissue destruc-
tion, and disease. Furthermore, we found that levels of
MBL were elevated in human patients suffering from RRV-
induced polyarthritis and MBL levels correlated with
disease severity. Taken together, our data implicates a
role for MBL in mediating RRV-induced disease in both
humans and mice, and suggests that therapeutic targeting
of MBL may be an effective strategy for disease treatment
in humans.
MBL Is Required for RRV-Induced Arthritis/Myositis
PLoS Pathogens | www.plospathogens.org 2 March 2012 | Volume 8 | Issue 3 | e1002586pathways [21], the pathway(s) leading to complement activation by
arthritic alphaviruses is currently unknown. Therefore, mice
deficient in key components of the classical (C1q
2/2), alternative
(factor B, fB
2/2), or lectin (MBL-A/C
2/2, MBL-DKO) pathways
were assessed for their susceptibility to RRV-induced disease.
C1q
2/2,f B
2/2, MBL-DKO, or WT C57BL/6 mice were
inoculated with RRV in the footpad and assessed for weight loss
and scored for hind limb function as previously described [20].
RRV-infected WT mice showed signs of hind-limb weakness by 5
days post infection (dpi) and developed severe hind-limb weakness
by 7 dpi through 10 dpi (Figure 1A). RRV causes disease
independently of B cells and antibody [20], suggesting that the
classical pathway does not contribute to disease during RRV
infection. Consistent with this, C1q
2/2 mice exhibited severe
disease signs and hind-limb weakness similar to WT animals
(Figure 1A). Likewise, fB
2/2 mice developed severe RRV-induced
disease (Figure 1A), demonstrating that the alternative pathway of
complement activation is not required for RRV-induced disease,
though it is important to note that RRV-infected fB
2/2 mice
tended to develop more severe disease compared to WT mice,
suggesting that the alternative pathway is activated and may
actually play a protective role during RRV infection. In contrast to
C1q
2/2 and fB
2/2 mice, MBL-DKO mice infected with RRV
developed mild hind-limb weakness and exhibited reduced weight
loss compared to WT mice (Figure 1, A and B). Mock-infected
WT and MBL-DKO mice did not differ in weight gain (Figure S1)
and showed no signs of disease throughout the course of infection
(data not shown). While we cannot rule out a minor contribution
of the classical and alternative activation pathways or activation of
the lectin pathway through ficolins in development of RRV
disease, this data demonstrates that the lectin pathway initiated by
MBL plays an essential role in driving RRV-induced disease.
MBL contributes to damage within quadriceps muscle
Following infection of WT C57BL/6 mice, RRV replicates to
high levels within both the joints and skeletal muscle and elicits an
inflammatory infiltrate into these tissues [20]. Following the onset
of inflammatory cell infiltration, wild type mice develop severe
destructive myositis, which is a major aspect of virus-induced
disease in this mouse model, and we have previously shown that
muscle cell killing and disease is dependent upon both C3
activation and CR3 [8,9]. Therefore, to confirm the role of MBL
in driving RRV-induced disease, inflammatory pathology was
assessed within the quadriceps muscles of RRV-infected fB
2/2,
C1q
2/2, MBL-DKO, or WT mice by H&E staining of paraffin
embedded sections. At 10 dpi, a time point of peak RRV disease,
we observed similar inflammation and tissue pathology in fB
2/2,
C1q
2/2, and WT mice (Figure 1C). Inflammatory cells are
present in the quadriceps muscles of infected mice from all strains,
as indicated by the solid arrowheads. We observed tissue damage
in the quadriceps muscles in fB
2/2, C1q
2/2, and WT mice as
evidenced by the degeneration of the fibrous architecture of the
skeletal muscle (marked by open arrowheads). In contrast, RRV
infected MBL-DKO mice maintained the architecture of the
skeletal muscle with very little tissue damage, despite the presence
of inflammatory cells (Figure 1C), which was strikingly similar to
previous results demonstrating an essential role for C3 in RRV-
induced disease [8]. To confirm that MBL-DKO mice have
decreased tissue damage following RRV infection compared to
WT mice, we used Evans Blue dye (EBD) uptake to detect areas of
damage. Consistent with the clinical scores and histological
analyses at 10 dpi, RRV-infected WT mice had abundant EBD
positive muscle fibers within the quadriceps muscle whereas EBD
positive cells were rare in RRV-infected MBL-DKO mice
(Figure 1D), further demonstrating that MBL is required for the
induction of tissue damage during RRV-induced disease.
RRV infection induces MBL deposition onto tissues and
cells
To determine if MBL is deposited onto tissues following RRV
infection, we evaluated tissue homogenates of quadriceps muscle
from RRV-infected WT mice at 7 dpi for levels of MBL by
immunoblot analysis. We observed an increase in the amount of
MBL in the quadriceps muscle of infected mice compared to that
of mock-infected mice (Figure 2A), indicating that RRV infection
results in elevated amounts of MBL within target tissues. Given the
enhanced MBL within RRV infected muscle tissue, we next
evaluated whether MBL would directly bind to RRV or RRV
infected cells. Studies with two other alphaviruses, CHIKV and
Sindbis virus, found no evidence for interactions with MBL, while
mosquito derived West Nile virus was efficiently bound and
neutralized by MBL [18]. Consistent with these findings, we were
unable to detect direct binding between MBL and either
mammalian cell or mosquito cell derived RRV virions by ELISA
(data not shown) and we also found no evidence for MBL-
mediated neutralization of RRV (Figure S2). Given the lack of
detectable interactions between MBL and the RRV virion, we
assessed whether MBL bound to RRV-infected cells. Differenti-
ated C2C12 murine skeletal muscle cells were infected with RRV
for 24 hours and then incubated with medium containing either
C57BL/6 wild-type serum or MBL-DKO serum for 30 minutes.
Cell lysates were harvested and analyzed for presence of MBL-C
by immunoblot analysis. As shown in Figure 2B, the amount of
MBL-C deposition was enhanced in cells infected with RRV
compared to mock infected cells, indicating that RRV infection
results in increased MBL binding to cells. No deposition of MBL
was detected onto cells incubated with MBL-DKO serum,
indicating the specificity of detection. Therefore, though MBL
does not appear to interact with the RRV virion, RRV infection
does lead to MBL deposition on infected cells.
Complement deposition and activation is reduced in
RRV-infected MBL-DKO compared to WT mice
MBL, but not the alternatively or classical complement
activation pathways, was required for RRV-induced disease and
tissue pathology (Figure 1), and the phenotype in MBL-DKO mice
is strikingly similar to C3
2/2 mice, suggesting that MBL plays a
major role in driving complement activation during RRV
infection. Therefore, we directly assessed whether MBL was
required for RRV-dependent complement deposition. Western
blot analysis of skeletal muscle from wild type or MBL-DKO mice
indicated that C3 levels, including the a and b chains of C3 were
present at reduced levels in the skeletal muscle of RRV infected
MBL-DKO mice compared to wild type mice (Figure S3A–B).
However, since inflammatory macrophages produce C3 [22],
western blot analysis was not able to clearly differentiate between
complement deposition within the tissue and de novo production
of complement by the infiltrating inflammatory cells in both wild
type and MBL-DKO animals. Therefore, we directly assessed the
impact of MBL deficiency on complement deposition within the
RRV infected muscle by performing immunohistochemistry on
quadriceps muscle from WT and MBL-DKO mice using an anti-
mouse C3 antibody. Abundant C3 staining localized to damaged
skeletal muscle at 7 dpi in WT mice while C3 staining was
substantially reduced in muscle from RRV-infected MBL-DKO
mice (Figure 2C). Importantly, we observed comparable C3
staining between RRV-infected C1q
2/2,f B
2/2, and WT mice
MBL Is Required for RRV-Induced Arthritis/Myositis
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C3 deposition on muscle tissue following RRV infection.
Therefore, these results suggest that MBL is the major mediator
of complement activation and deposition within RRV infected
muscle tissue.
Viral replication is unaffected in the muscle tissue of
MBL-DKO mice
Prior studies with C3
2/2 and CR3
2/2 mice demonstrated that
complement activation and CR3-dependent signaling is essential
for RRV-induced disease and tissue destruction, but complement
deficiency had no effect on viral burden or tropism. To determine
whether this was also the case in MBL-DKO mice, we evaluated
WT and MBL-DKO mice for viral load within the quadriceps
muscles, ankle joints, and serum. As shown in Figure 3A, MBL-
DKO mice exhibited no significant difference in the amount of
infectious virus in the quadriceps muscle through days 7 and
10 dpi, which represent the times when RRV-induced muscle
destruction peaks. Furthermore, analysis of the viral distribution
within wild type and MBL-DKO animals by in situ hybridization
found no differences in the localization of RRV specific signal
between the two mouse strains. (Figure 3D). Therefore, the
Figure 1. MBL is required for development of severe RRV-induced disease and tissue damage. (A–B) Twenty-four day old WT C57BL/6
(solid square, n=6), C1q
2/2 (open square, n=6), fB
2/2 (solid circle, n=5), or MBL-DKO (open circle, n=6) mice were infected with RRV, scored for
hind limb function based on a scale described in the Materials and Methods, and assessed for weight loss. Each data point represents the arithmetic
mean 6SD and is representative of at least three independent experiments. We performed a Mann-Whitney analysis with multiple comparison
corrections (p,0.01 was considered significant) on clinical scores at 10 dpi and a one-way ANOVA analysis with Bonferroni’s correction on percent of
starting weight at 10 dpi (p,0.05 was considered significant) to determine significance between the various knock-out lines compared to WT
**p,0.01; *** p,0.001; n.s. not significant. (C) Tissue pathology and inflammation was examined at 10 dpi by H&E staining of paraffin embedded
sections of quadriceps muscle. A representative section from each knockout strain is shown. A section from RRV-infected C3
2/2 is shown for
comparison. Solid arrowheads point to areas of inflammation; open arrowheads indicate tissue damage (D) To assess damage within the muscle,
mock or RRV-infected WT or MBL-DKO mice were injected with EBD at 10 dpi, and frozen sections were generated. EBD positive muscle fibers were
identified by fluorescence microscopy. Representative sections of mock- and RRV-infected mice are shown and are representative of two
independent experiments.
doi:10.1371/journal.ppat.1002586.g001
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PLoS Pathogens | www.plospathogens.org 4 March 2012 | Volume 8 | Issue 3 | e1002586Figure 2. RRV infection induces MBL deposition onto cells, resulting in MBL-dependent C3 deposition onto infected tissues. (A) To
determine if MBL levels are elevated within the quadriceps muscles of RRV-infected wild-type animals, homogenized quadriceps muscles from either
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C3 deposition (Figure 2C) within the RRV infected muscle of
MBL-DKO mice cannot be explained by differences in viral
replication.
In addition to evaluating viral titers within the skeletal muscle, we
also assessed viral loads within the serum and ankle joints. Viral
titers within the ankle joints were similar between MBL-DKO and
WT mice through 7 dpi (Figure 3B), though we did observe a small,
but statistically significant decrease in viral titer within the ankle
joints of MBL-DKO mice compared to wild type mice at day 10
post infection. MBL-DKO mice had higher amounts of virus in the
serum at 1 dpi compared to WT mice (Figure 3C), indicating that
MBL may play some role in initial control of viremia. However,
virus was cleared from the serum of infected animals at similar rates
inbothWTandMBL-DKOmice(Figure3C),suggestingthatMBL
does not play a major role in serum clearance of RRV or direct
neutralization of virus in the serum. The impact of this initial
increase in serum viremia in MBL-DKO mice on downstream
disease through antibody production is unclear, although it is
important to note that both RAG-1
2/2 and mMT mice develop
disease similar to WT mice [8], indicating that the antibody
response is not required for development of disease.
mock- or RRV-infected WT mice at 7 dpi were analyzed by immunoblot analysis using anti-mouse MBL-A, anti-mouse MBL-C, or anti-mouse actin
antibodies. Each lane represents an individual mouse and is representative of at least three independent experiments. Densitometry measurements
of bands in immunoblot from three different experiments are graphically depicted as arbitrary units normalized to actin (mock n=4; RRV n=9). (B) To
determine if MBL deposition is enhanced onto RRV-infected cell, differentiated C2C12 murine skeletal muscle cells were infected with RRV, and
incubated with either serum from a WT or MBL-DKO mouse for 30 minutes prior to harvesting. Cells were washed, harvested, and lysates were
analyzed by immunoblot analysis using anti-mouse MBL-C, anti-RRV, or anti-mouse actin antibodies. Densitometry measurements of bands in
immunoblot are graphically depicted as arbitrary units normalized to actin (C) C3 deposition was assessed by IHC using an anti-mouse C3 antibody
on quadriceps muscle sections from either mock- or RRV-infected WT or MBL-DKO mice at 7 dpi. C3 positive areas are stained in blue. A
representative section from each strain is shown and is representative of two independent experiments. No signal was observed in sections
incubated with a control goat IgG antibody.
doi:10.1371/journal.ppat.1002586.g002
Figure 3. MBL deficiency does not affect viral replication or tropism within infected tissues. (A–C) Quadriceps muscle (A), ankle joints (B),
and serum (C) from RRV-infected WT (solid circles, n=3–9/time point) or MBL-DKO (open circles, n=3–8/time point) mice were assayed to determine
viral titer at various times post infection. Viral titer was determined by plaque assay on BHK-21 cells. Each data point represents the viral titer froma
single animal; data is combined from two independent experiments. *p,0.05 as determined by t-test. (D) Tropism within the quadriceps muscle
tissue was determined by in situ hybridization using RRV-specific probe. We did not detect any signal using an EBER-specific probe (data not shown).
A representative section from each strain is shown (n=3 for both WT and MBL-DKO mice).
doi:10.1371/journal.ppat.1002586.g003
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recruitment, but alters expression of inflammatory
mediators within the RRV-infected muscle
Prior studies demonstrated that complement activation drives
inflammatory tissue destruction, but does not regulate inflamma-
tory cell recruitment during RRV infection [8]. However, as MBL
may regulate the host inflammatory response independently of its
effects on complement activation, we quantified and analyzed the
inflammatory cell populations within the muscle of WT and MBL-
DKO animals at 7 and 10 dpi, which are the times of peak
inflammation in WT mice [20]. Consistent with prior findings in
C3
2/2 mice, RRV infected MBL-DKO mice exhibited no
statistically significant differences in either total number of
leukocytes (Figure 4A and Figure S4A) or the composition of the
inflammatory infiltrates at either 7 or 10 dpi (Figure 4B and Figure
S4B). Representative flow cytometry plots of the various cell types
are shown in Figure S5. The total numbers of CD4
+ T cells, CD8
+
T cells, and NK cells at both 7 and 10 dpi were not significantly
different between RRV-infected WT and MBL-DKO mice
(Figure 4B and Figure S4B). Given the role of inflammatory
macrophage in development of RRV-induced disease [6], we
compared total numbers of cells with staining characteristics of
inflammatory macrophages (F4/80
+ CD11b
+ Gr-1
lo B220
2)a t
both 7 and 10 dpi, and observed no difference at 7 dpi, and
interestingly, a significant increase in numbers of these cells in
RRV-infected MBL-DKO mice at 10 dpi. While we cannot rule
out the possibility that minor populations of inflammatory cells are
differentially regulated by MBL, these data suggest that MBL does
not affect the major populations of inflammatory infiltrates
recruited to the skeletal muscle following RRV infection.
Although inflammatory cell recruitment was largely unaffected
by either MBL or C3 deficiency [8] we have previously shown
CR3 is also required for RRV-induced disease and that a subset of
inflammatory genes expressed in the inflamed muscle of RRV-
infected mice are dependent upon both C3 and CR3, including
the calgranulins S100A8 and S100A9, IL-6 and the enzyme
arginase I (ArgI) [9]. Therefore, to determine if MBL affected
expression of these genes in the same manner as C3 and CR3,
expression levels were assessed in the quadriceps muscle from both
WT and MBL-DKO mice at 7 dpi. As shown in Figure 4C, RRV-
infected WT mice exhibited significantly higher expression of
S100A8 and S100A9 compared to RRV-infected MBL-DKO
mice, indicating that expression of these genes is also regulated by
MBL during RRV infection. Interestingly, the S100A8/S100A9
complex has been associated with inflammatory arthritis (reviewed
in [23]) however, the role of these proteins in RRV disease
requires further investigation. Expression of TNFa and IL-1b,
which were shown to be C3-independent [9], were also unaffected
in MBL-DKO mice (Figure 4C). Expression of IL-6 and Arg I,
which we have previously shown to be C3 and CR3-dependent,
were unaffected in MBL-DKO mice (IL-6) or slightly reduced (Arg
I) (Figure 4C). Expression of these genes may reflect residual
complement activation in the absence of MBL (Figure S3), though
this requires further study. Interestingly, expression of IL-10,
which is largely C3-independent following RRV infection [9], was
dependent on MBL and suggests that MBL may be interacting
with pathways other than the complement system to mediate IL-
10 expression (Figure 4C).
Levels of MBL are elevated in RRV patients
Prior studies have shown that the C3 cleavage product C3a is
elevated in synovial fluid of RRV polyarthritis patients [8].
To determine if circulating levels of MBL are elevated in
RRV-infected patients, we compared serum MBL levels from
patients during convalescence to serum MBL levels in RRV-
seronegative controls. As shown in Figure 5A, RRV patients had
significantly higher levels of circulating MBL compared to healthy
controls. Since MBL levels are highly variable in human
populations, we also assessed serum and synovial fluid MBL levels
in a small cohort of patients clinically characterized as having severe
or mild RRV-induced polyarthritis. MBL levels correlated with
severity of RRV disease (Figure 5B), with higher levels of MBL
observed in patients classified as having severe disease. Severity of
disease also correlated with increased levels of C4a in the synovial
fluid (Figure 5C), which could result from complement activation
through either the lectin or classical pathway. However, analysis of
the level of C1q-C4 complexes formed within the synovial fluid, an
activation marker of the classical pathway [24], showed no
difference between patients with severe or mild disease
(Figure 5C), suggesting that the higher C4a levels in severe RRV
disease was primarily due to activation through the lectin pathway.
In addition, we did not observe a difference in levels of Bb, an
activation marker of the alternative pathway (Figure 5C), further
supporting the hypothesis that the MBL pathway primarily
mediates complement activation following RRV infection. Impor-
tantly, when we assessed MBL levels in a cohort of patients suffering
from non-inflammatory osteoarthritis, we found no evidence for
elevated MBL levels (mean MBL levels of 57.8624.8 ng/ml [n=5
patients with severe osteoarthritis]) compared to MBL levels of
4856163.7 ng/mlinpatientswithsevereRRVinduceddisease and
218.5682.4 ng/ml within the synovial fluid of patients with mild
RRV-induced disease, suggesting that elevated levels of MBL are
not simply the result of arthritis symptoms within the joints.
Although additional studies with a larger cohort of patients are
required to determine whether MBL levels associate with the
severity of RRV-induced arthritis, and whether this effect reflects a
causal role for MBL in human disease, these results, combined with
the knockout mouse studies strongly suggest that the MBL pathway
of complement activation plays a major role in the pathogenesis of
RRV-induced inflammatory disease.
Discussion
Alphaviruses such as CHIKV and RRV represent significant
emerging disease threats that cause large-scale outbreaks of severe
chronic and persistent arthralgia/myalgia in human populations.
Though alphavirus-induced arthralgia and myalgia is often
debilitating, the mechanisms by which these viruses cause
arthritis/arthralgia are not fully understood. Previous studies have
shown that inflammatory macrophages play a major role in the
pathogenesis of both RRV and CHIKV [6,25], that the host
complement cascade is essential for the induction of muscle
destruction by these inflammatory cells during RRV infection, and
that this process is dependent on complement receptor 3 (CR3)
[8,9]. The data presented here demonstrate that RRV infection
results in the deposition of MBL within RRV infected tissues, and
that MBL, but not the alternative or classical complement
activation pathways, was essential for RRV induced complement
activation and subsequent inflammatory tissue destruction and
disease. Consistent with this, humans suffering from severe RRV
disease exhibited increased levels of MBL, but not markers of the
classical or alternative complement activation pathways in their
synovial fluid. Therefore, these studies demonstrate that MBL
plays a key role in promoting the pathogenesis of alphavirus-
induced inflammatory disease, and suggest that MBL may
represent a target for therapeutic intervention in the treatment
of alphavirus-induced arthritis/myositis.
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viral infection, either through its ability to neutralize viruses
directly or via the downstream activation of complement. In the
context of arbovirus infection, MBL contributes to direct
neutralization of mosquito-derived West Nile virus and both
mammalian and mosquito-derived dengue virus through interac-
tions between MBL and viral N-linked glycans [18,26], and MBL
contributes to protection from West Nile virus-induced disease in
vivo [19]. Though the host complement cascade has been shown
to play a protective role during neurotropic alphavirus infection
[21,27,28] these processes are dependent upon either the classical
or alternative complement activation pathways [21]. Furthermore,
though Fuchs, et al., found that MBL bound and neutralized
WNV virions, they found no evidence for MBL interactions with
two alphaviruses, CHIKV and Sindbis virus [18], which is
supported by our inability to demonstrate direct binding or
neutralization of RRV virions by MBL. Therefore, our findings
demonstrate a novel role for MBL in the pathogenesis of
alphavirus-induced arthritis/myositis and indicate that this
pathway, which plays a protective role against many viral
infections, is actually a major driver of RRV-induced tissue
pathology and disease.
In addition to its prominent role in the pathogenesis of RRV-
induced disease, the complement cascade is linked to a number of
host autoimmune inflammatory disorders, including rheumatoid
arthritis (reviewed in [29]). However, the role of MBL in these
processes is less clear. Though MBL has been shown to contribute
to ischemic injury in mouse models of cardiac or intestinal
reperfusion injury [12–15], MBL has not been directly linked to
inflammatory arthritis. There are conflicting reports associating
MBL polymorphisms with rheumatoid arthritis in humans [30–
34], however in mouse models of collagen-induced arthritis, which
serves as a model of RA, MBL is dispensable for complement
activation and arthritis induction [35,36]. Therefore, MBL
appears to be playing a unique role in the pathogenesis of
RRV-induced arthritis/myositis that is not shared with other
arthritic syndromes, though further comparisons between these
different disease states are needed to clarify this issue.
The studies presented here demonstrate that MBL-dependent
complement activation promotes RRV-induced disease and raises
several questions relating to the mechanism of RRV activation of
complement, the role of MBL polymorphisms in determining
disease severity, and the therapeutic potential of MBL inhibition to
treat RRV-infected patients. The CRD of MBL recognizes
terminal carbohydrates, such as mannose and glucose, which
can be found on glycosylated proteins in bacteria and viruses. The
RRV glycoproteins contain three N-linked glycosylation sites that
are glycosylated with a combination of high mannose and complex
glycans [37] and may serve as ligands for MBL, leading to
complement activation. While we did not observe direct binding of
MBL to virions, we did observe an increase in the amount of MBL
deposited onto infected tissues and on virally infected cells
(Figure 2), indicating that some aspect of RRV infection induces
MBL deposition and complement activation. Alphaviruses bud
from the plasma membrane of infected cells and the viral
glycoproteins are prominently exposed on the surface of the cell.
Therefore, it is possible that MBL is recognizing and binding to
viral glycoproteins on infected tissues during viral egress, resulting
in complement activation directly onto the tissue rather than
binding to free virus. Alternatively, viral infection may lead to the
modification of host cell N-linked glycans or other cellular
components, thereby promoting MBL deposition and complement
activation; however, both of these possibilities require further
investigation.
Given the central role of MBL in development of severe RRV-
induced disease, specific inhibition of the MBL activation pathway
of the complement system in RRV-patients may be a strategy to
alleviate disease. Current therapy involves administration of non-
steroidal anti-inflammatory drugs, and given the role that
complement plays in mediating severe RRV-induced disease,
treatment with complement inhibitors may provide an attractive
alternative to nonspecific anti-inflammatory drugs. However,
prolonged inhibition of the complement system can leave patients
susceptible to other infectious diseases, especially as treatment of
disease symptoms may require several months for some individuals
[38]. Our results suggest that a more focused approach targeting
MBL may prove effective in limiting RRV-induced arthralgia/
myalgia, while limiting the general immune suppression associated
with complement inhibition. Inhibitors targeting the MBL
pathway of complement through inhibition of MASP-2 are in
development [39], and may be useful in treatment of RRV-
induced disease in humans.
In addition to raising the possibility of targeting MBL in the
treatment of RRV or other alphavirus-induced arthraligias/
myalgias, these studies raise the issue of whether polymorphisms
in MBL affect susceptibility to RRV-induced disease. Common
genetic polymorphisms within the promoter region and exon 1 of
the human Mbl2 gene lead to variations in serum MBL levels or
functional deficiency of MBL (reviewed in [40]). Human patients
with severe RRV disease have higher levels of MBL within the
synovial fluid and serum; however, it is unclear if levels of MBL
are elevated in response to severe RRV infection or if naturally
higher levels of MBL contribute to the development of severe
disease. Preliminary analysis of a small cohort of RRV patients
does not associate Mbl2 polymorphisms with severity of RRV
disease (S. Mahalingam, B. Piraino, B. Cameron, L. Herrero, and
A. Lloyd, unpublished data), however a larger cohort of RRV-
infected individuals must be analyzed before we can conclude
whether MBL polymorphisms associate with RRV-induced
disease severity or if up-regulation of MBL in response to viral
infection contributes to disease pathogenesis in humans.
In summary, the data presented in this study demonstrate the
role for MBL in promoting severe disease following RRV infection
through complement activation and subsequent destruction of
RRV infected tissue. Numerous studies have shown a protective
role for MBL and the complement system in response to a diverse
set of viruses. Our results demonstrate a novel role of MBL
following viral infection in which MBL contributes to development
Figure 4. MBL deficiency does not affect inflammatory cell recruitment, but alters expression of inflammatory mediators within the
RRV infected muscle. (A–B) Leukocytes were isolated from the quadriceps muscle of RRV-infected WT (solid circles, n=3–5/time point) or MBL-DKO
(open circles, n=3–7/time point) mice at 7 or 10 dpi. Cells were characterized and quantified by flow cytometry using the markers described in the
materials and methods. Total numbers of leukocytes (A) and specific cells types (B) are shown. A single experiment for each time point is shown.
Compiled data for three independent experiments is shown in Fig. S4 (7 dpi). *p,0.05 by Mann-Whitney analysis. (C) Relative mRNA expression of
C3-dependent inflammatory mediators and cytokines S100A9, S100A8, Arginase I, and IL-6 (top panel) and C3-independent cytokines TNFa, IL-1b,
and IL-10 (bottom panel) from quadriceps muscle from RRV-infected WT (solid bar, n=3) or MBL-DKO (open bar, n=3) mice by quantitative real-time
PCR. Raw data values were normalized to 18S rRNA levels, log-transformed, and are graphically depicted as fold expression over mock-infected mice.
Data from a single experiment is shown, but is representative of two independent experiments. ***p,0.001; **p,0.005 by t-test.
doi:10.1371/journal.ppat.1002586.g004
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therapeutic target for treatment in humans suffering from RRV-
induced polyarthritis or other alphavirus-induced arthritides.
Materials and Methods
Ethics statement
Some of the studies described in this manuscript did involve
human samples. For human serum samples, all serum samples had
been submitted for diagnostic testing with written and oral
informed patient consent at CIDMLS, Westmead Hospital and
The Royal Melbourne Hospital (Melbourne, Australia). Samples
were de-identified by the testing laboratory before being used in
the research project. Synovial samples were collected from adult
patients (age range, 30–45 years) residing in the Murray-Goulburn
Valley (Victoria, Australia) who had acute cases of RRV-induced
polyarthritis in accordance with human subjects protocols
approved by the Royal Melbourne Hospital Human Ethics
Committee. All individuals received and completed written
informed consent forms prior to collection of materials. Mouse
studies were performed in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. All mouse studies were
performed at the University of North Carolina (Animal Welfare
Assurance # A3410-01) using protocols approved by the UNC
Institutional Animal Care and Use Committee (IACUC). All
studies were performed in a manner designed to minimize pain
and suffering in infected animals, and any animals that exhibited
severe disease signs was euthanized immediately in accordance
with IACUC approved endpoints.
Viruses and cells
The viral stocks used in this study were generated from the
infectious clone of the T48 strain of RRV (pRR64), kindly
provided by Richard Kuhn (Purdue University) as described in
[20]. Briefly, viral RNA was generated through in vitro transcrip-
tion of SacI-linearized pRR64 using the mMessage mMachine
SP6 kit (Ambion) and electroportated into BHK-21 cells (ATCC).
Viral titer was determined by plaque assay on BHK-21 cells.
BHK-21 cells were grown in a-MEM (Gibco) supplemented with
10% donor calf serum (DCS), 10% tryptose phosphate, L-
glutamine, penicillin, and streptomycin. C2C12 cells were grown
in DMEM (Gibco) supplemented with 20% fetal bovine serum
(FBS), L-glutamine, penicillin, and streptomycin prior to differen-
tiating. To differentiate cells into myotubes, confluent C2C12 cells
were maintained in DMEM supplemented with 2% horse serum,
L-glutamine, penicillin, and streptomycin.
Mice
All mice used in this study were maintained and bred in house
at the University of North Carolina (UNC) in accordance with
UNC Institutional Animal Care and Use Committee guidelines.
C57BL/6 and MBL-DKO mice were purchased from The
Jackson Laboratories (Bar Harbor, ME); C1q
2/2 mice were a
generous gift from Dr. Marina Botto (Imperial College London,
UK); fB
2/2 mice were generously provided by Dr. Charles
Jennette (UNC). While RRV is classified as a biosafety level-2
agent, due to the exotic nature of the virus, all animal studies were
performed in a biosafety level-3 facility. Twenty-four day old mice
were inoculated with 10
3 PFU of RRV in diluent (phosphate
buffered saline supplemented with 1% DCS) into the left rear
footpad. Mice were weighed daily and assigned a clinical score
based on hind limb weakness and altered gait on the following
scale: 0=no disease; 1=mild loss of hind limb grip; 2=moderate
loss of hind limb grip; 3=severe loss of hind limb grip; 4=no hind
limb grip and mild inability to right; 5=no hind limb grip and
complete inability to right; 6=moribund.
Viral burden analysis
Mice were infected with RRV as described above, and at
indicated times post infection mice were sacrificed, perfused with
16 PBS, and indicated tissues were dissected out, weighed, and
homogenized with glass beads in diluent. Viral titer within infected
tissues were determined by plaque assay on BHK-21 cells from
tissue homogenates.
In situ hybridization
Mice were infected with RRV as described above, and at
indicated times post infection mice were sacrificed, perfused with
4% paraformaldehyde (PFA), pH 7.3. Tissues were paraffin
embedded and 5 mm sections were generated and in situ
hybridization was performed as previously described [20] using
an RRV-specific or EBER-specific
35S-labeled RNA probe.
Histological analysis
At desired times post infection, mice were sacrificed and
perfused with 4% paraformaldehyde (PFA), pH 7.3. Tissues were
paraffin embedded and 5 mm sections were generated and stained
with hematoxylin and eosin (H&E) to examine tissue pathology
and inflammation. Sections were visualized by bright field light
microscopy (Olympus BX61).
Evans blue dye uptake analysis
At 10 days post infection mice were injected with 1% Evans
blue dye in PBS into the peritoneal cavity (50 ml/10 g mouse
weight). At 6 hours post injection, mice were sacrificed and
perfused with 4% PFA. Quadriceps muscle tissues were embedded
in optimal cutting temperature compound (OCT) and frozen in an
isopentane histobath, 5 mm sections were generated, mounted with
ProLong Gold with DAPI (Invitrogen) and sections were analyzed
by fluorescence microscopy (Olympus BX61).
Immunohistochemistry
At 7 dpi, mice were sacrificed and perfused with 4% PFA.
Quadriceps muscles were removed, paraffin embedded, and 5 mm
sections were generated. Sections were deparaffinized in xylene,
rehydrated through an ethanol gradient, and probed with a goat
anti-mouse C3 polyclonal antibody (1:500 Cappel) using the
Vectastain ABC-AP kit (Vector Labs, CA) and Vector Blue
Alkaline phosphatase substrate kit (Vector Labs, CA) according to
the manufacturers’ instructions. Sections were counterstained with
Gill’s hematoxylin.
Figure 5. Levels of MBL are elevated in RRV patients. (A) Serum from RRV-infected patients (solid circles, n=5) or healthy sero-negative
controls (open circles, n=13) were analyzed by ELISA for MBL levels. Each data point represents a single individual, and bar represents the median.
*p,0.05 by Mann-Whitney analysis. (B) MBL levels within serum and synovial fluid from patients clinically characterized with either severe RRV-
induced disease (solid circles, n=6) or mild RRV-induced disease (open circles, n=4) were analyzed by ELISA. Each data point represents a single
individual, and the bar represents the median. **p,0.01 by Mann-Whitney analysis. (C) Levels of C4a (left), C1q-C4 complex (middle) and Bb (right)
within the synovial fluid from patients described in (B) were analyzed by ELISA. *p,0.05 by Mann-Whitney analysis.
doi:10.1371/journal.ppat.1002586.g005
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At indicated times post infection, mock-infected and RRV-
infected mice were sacrificed, and perfused with 16 PBS.
Quadriceps muscles were removed and homogenized in radioim-
munoprecipitation lysis buffer (RIPA; 50 mM Tris pH 8.0,
150 mM NaCl; 1% NP-40, 0.5% deoxycholate, 0.1% SDS and
16 complete protease inhibitor cocktail (Roche)) by glass beads.
Protein concentration was determined by Bradford protein assay
and 25–30 mg of protein was run onto a 10% SDS-PAGE gel.
Protein was transferred onto a PVDF membrane, and membranes
were blocked in 5% milk, 0.1% Tween-20 in PBS. Membranes
were probed with goat anti-mouse MBL-A (1:1000 R&D Systems),
goat anti-mouse MBL-C (1:1000 R&D Systems), goat anti-mouse
C3 polyclonal antibody (1:1000 Cappel), mouse anti-RRV (1:1000
ATCC), or goat anti-mouse actin polyclonal antibody (1:500
SCBT), washed with PBS containing 0.1% Tween-20 and
incubated with rabbit anti-goat antibody or sheep anti-mouse
antibody conjugated to horseradish peroxidase (1: 10, 000 Sigma).
Membranes were washed again and protein visualized by ECL
(Amersham) according to manufacturer’s instructions. Densitom-
etry was performed using ImageJ software (NIH).
MBL deposition onto C2C12 cells
Differentiated C2C12 cells were either mock-infected or
infected at an approximate MOI of 20 with RRV. At 24 hpi,
culture medium was removed and cells were incubated in
differentiation medium containing either 10% serum from WT
or MBL-DKO mice for an additional 30 minutes. Cells were
washed and harvested in RIPA lysis buffer, and cell lysates were
analyzed by immunoblot analysis.
Analysis of infiltrating inflammatory cells by flow
cytometry
To determine the composition of the inflammatory cell
infiltrates within the quadriceps muscle, at indicated times post
infection mice were sacrificed and perfused with 16 PBS. Both
quadriceps muscles were removed, minced, and digested with
RPMI containing 10% fetal bovine serum (FBS), 15 mM HEPES,
2.5 mg/ml collagenase A (Roche), 1.7 mg DNase I (Roche) for
2 hours at 37uC with shaking. Cells were strained through a
40 mm strainer and washed twice with wash buffer (HBSS
containing 1% sodium azide and 1% FBS) and total viable cells
were determined by trypan blue exclusion. To stain cells for flow
cytometry, cells were incubated with anti mouse FcgRII/III
(2.4G2; BD Pharmingen) and stained with combinations of the
following antibodies: fluorescein isothiocyanate (FITC)-conjugated
anti-mouse CD3, phycoerythrin (PE)-conjugated anti-NK1.1, PE-
Cy5 anti-CD45 (leukocyte common antigen), PE-Cy7 anti-F4/80,
Allophycocyanin (APC)-conjugated anti-CD49b, eF450-conjugat-
ed anti-CD11b, APC anti-major histocompatibility complex class
II antigens (MHC II), and eF780-conjugated anti-CD45 (B220)
(eBiosciences, San Diego, CA), FITC anti-Ly-6G, and PE anti-
SigLecF (BD-Pharmingen, San Diego, CA), and PE-Texas Red-
conjugated anti-CD45 (B220), and PE-Texas Red anti-CD11c
(Molecular Bioprobes, Invitrogen). Cells were fixed with 2% PFA
(pH 7.3) and analyzed on a CyAn flow cytometer (Becton
Dickinson), and data was analyzed using Summit software.
Gene expression
At 7 dpi following RRV infection, mice were sacrificed and
perfused with 16 PBS. Quadriceps muscles were removed and
homogenized in Trizol (Invitrogen) using glass beads. RNA was
extracted using Invitrogen PureLink RNA purification kit, and
mRNA expression of indicated genes was measured by quantita-
tive real-time PCR. Raw data values were normalized to 18S
rRNA levels.
Patient samples
Convalescent serum samples from five patients presenting with
acute, serologically confirmed (seroconversion by neutralization,
IgM and IgG) RRV-infection and thirteen samples from healthy
individuals were provided by CIDMLS, Westmead Hospital
(Sydney, Australia). All serum samples had been submitted for
diagnostic testing with informed patient consent at CIDMLS,
Westmead Hospital and The Royal Melbourne Hospital (Mel-
bourne, Australia). Samples were de-identified by the testing
laboratory before being used in the research project. Needle
biopsy was performed to collect synovial fluid samples from adult
patients (age range, 30–45 years) residing in the Murray-Goulburn
Valley (Victoria, Australia) who had acute cases of RRV-induced
polyarthritis. Samples were collected and prepared aseptically in
the laboratories of Echuca Hospital (Murray-Goulburn Valley;
Victoria, Australia) and The Royal Melbourne Hospital and was
performed in accordance with The Royal Melbourne Hospital
Human Ethics Committee. Severe RRV-induced disease was
defined as a patient presenting with intense swelling, severe joint
pain and myalgia affecting both the knee joints and joints of the
fingers. Mild RRV-induced disease was defined as a patient
presenting with minor swelling, localized in the knees, and no
additional symptoms. For osteoarthritis samples, synovial fluid
aspirates were obtained from 5 patients with osteoarthritis from
the John James Hospital (Canberra, Australia). Sample collection
was performed in accordance with the AustralianCapital Territory
Health Community Care Human Research Ethics committee.
Samples were obtained at the time that knee joint arthroplasty was
performed, and joints were aspirated before arthrotomy. The
diagnosis given to patients was primary osteoarthritis with no
evidence of an inflammatory arthropathy. These samples were de-
identified prior to analysis.
Levels of MBL in serum and synovial fluid were determined
using a commercially available ELISA kit according to the
manufacturer’s instructions (R&D Systems). Levels of C4a in the
synovial fluid was determined using BD OptEIA (BD). Bb levels
were determined using Microvue Bb Plus (Quidel). The levels of
the C1q-C4 complex were determined as described in [24].
Statistical analysis
Clinical scores and percent of starting weight at 10 dpi between
C1q
2/2,f B
2/2, MBL-DKO, and wild-type mice were analyzed
for statistically significant differences by Mann-Whitney analysis
with multiple comparisons corrections (clinical scores; p,0.01 is
considered significant), and by one-way ANOVA with Bonferro-
ni’s correction (percent of starting weight; p,0.05 is considered
significant). Viral burden, total number of infiltrating cells, and
gene expression data at each time point between wild-type and
MBL-DKO mice was analyzed for statistically significant differ-
ences by Mann-Whitney analysis or t-test (p,0.05 is considered
significant). Levels of MBL, C4a, C1q-C4 complexes, and Bb in
serum and synovial fluid from human patients were analyzed by
Mann-Whitney analysis for statistical significance (p,0.05 is
considered significant). Statistical analyses were performed using
GraphPad Prism 5.
Supporting Information
Figure S1 C57BL/6 wild-type and MBL-DKO mock-
infected control mice exhibit weight gain throughout
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(solid circle, n=5–13/time point) or MBL-DKO (open circle,
n=5–17/time point) mice were inoculated with 10 ml of diluent
and assessed for weight loss. Each data point represents the
arithmetic mean 6SD of weights measured across twelve different
experiments.
(TIF)
Figure S2 MBL does not neutralize RRV. To determine if
RRV could be directly neutralized by complement components
within serum, 10
3 PFU of RR64 was incubated with increasing
amounts of naı ¨ve mouse serum from wild-type (solid circle) or
MBL-DKO mice (solid square), or heat-inactivated wild-type
serum (open circle) for 1 hour at 37uC. The number of plaques
was determined by plaque assay on BHK-21 cells. Each data point
represents the arithmetic mean 6 SD of three replicates and is
representative of three independent experiments.
(TIF)
Figure S3 Complement activation within quadriceps
muscle is largely dependent on MBL. (A–B). (A) To
determine if complement activation was dependent on MBL, we
analyzed homogenized quadriceps muscles from either mock- or
RRV-infected WT or MBL-DKO mice 7 dpi by immunoblot
analysis using an anti-mouse C3 or anti-mouse actin antibody. C3
cleavage products are indicated with solid arrowheads. Each lane
represents an individual mouse, and the western blot is
representative of three independent experiments (B) Densitometry
measurements of bands in immunoblots from three independent
experiments are graphically depicted as arbitrary units normalized
to actin (RRV-infected WT mice, solid circle n=9; MBL-DKO
mice, open circle n=10) (C) To determine if either the classical or
alternative complement activation pathways contribute to C3
deposition following RRV infection, we performed IHC using an
anti-mouse C3 on quadriceps muscle sections from RRV-infected
wild-type, C1q
2/2,o rf B
2/2 at 10 dpi. C3 deposition is shown in
red for C1q
2/2 and the wild-type control, and in blue for the fB
2/2
and wild-type control. 5 mm thick paraffin-embedded sections were
prepared as described in the Materials and Methods, with the
following modification: RRV-infected C1q
2/2 and wild-type
sections were developed using Vector Red Alkaline phosphatase
substrate kit (Vector Labs, CA) instead of Vector Blue Alkaline
phosphatase substrate kit. A representative section from each strain
is shown (n=3 for wild-type mice, n=3 for C1q
2/2 mice; n=3 for
wild-type mice, n=3 for fB
2/2 mice).
(TIF)
Figure S4 Inflammatory cell composition is not signif-
icantly different in RRV infected WT and MBL-DKO
mice. (A–B) Leukocytes were isolated from the quadriceps muscle
of RRV-infected WT mice (solid circle, n=5–12/time point) or
MBL-DKO (open circle, n=7–12/time point) at 7 or 10 dpi.
Cells were characterized and quantified by flow cytometry using
the markers described in the Materials and Methods. Total
numbers of leukocytes (A) and specific cells types (B) are shown.
Each data point represents an individual mouse and data
presented in this figure are combined from three independent
experiments (7 dpi). *p,0.05 by Mann-Whitney analysis.
(TIF)
Figure S5 Representative flow cytometry plots and
gating scheme used to characterize inflammatory infil-
trates. (A) To determine the number of leukocytes, we gated on
LCA
+ cells. To further distinguish between NK cells and T cells,
we analyzed expression of NK1.1 and CD3 on LCA
+ lympho-
cytes. NK1.1
+CD3
2 were classified as NK cells, and
NK1.1
2CD3
+ cells were classified as T cells. T cells were further
classified into CD4
+ and CD8
+ T cells based on CD4 and CD8
expression. Percentages displayed on plots represent the percent-
age of cells within the indicated gate. (B) To determine the number
of inflammatory macrophage, we first gated on LCA
+ cells,
followed by analysis of CD11b and B220 expression. Inflamma-
tory macrophage typically stain CD11b
+B220
2. We distinguished
inflammatory macrophage from neutrophils within the
CD11b
+B220
2 population by analyzing F4/80 and Gr-1/Ly-6G
expression; inflammatory macrophage were defined as
CD11b
+B220
2F4/80
+Gr-1
lo. Percentages displayed on plots
represent the percentage of cells within the indicated gate.
(TIF)
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